Cellular signaling pathways – no specific molecular target

The term "Cellular signaling pathways – no specific molecular target" serves as a placeholder or categorical label in drug discovery and clinical trial databases, such as the WHO International Clinical Trials Registry Platform (ICTRP), for agents whose primary molecular mechanism is not yet defined (Source: WHO ICTRP, 2024). It is frequently used for drugs identified through phenotypic screening, where the therapeutic effect is observed in a whole-cell or organismal model without prior knowledge of a specific protein target (Source: Nature Reviews Drug Discovery, 2011). These agents often influence broad biological functions, including signal transduction, cell cycle regulation, and apoptosis, by modulating complex networks rather than a single receptor or enzyme. Because no specific molecule is identified, this classification represents a challenge for precision medicine, as it precludes the use of target-based biomarkers for patient stratification. Historically, many drugs were approved under this category before modern chemical biology techniques, such as activity-based protein profiling, allowed for the retrospective identification of their true molecular targets (Source: ACS Chemical Biology, 2017). Consequently, this entry does not represent a biological entity but rather a state of incomplete mechanistic knowledge regarding a drug's interaction with cellular machinery.

Other names

Unspecified signaling pathwaysNon-specific molecular targetPhenotypic targetGeneral cellular signaling

Pleiotropic modulation of intracellular signaling cascades without a defined primary protein interaction.